A science-led guide to intestinal permeability — the real biology of your gut barrier, why the “cause of everything” claims go too far, and the genuine connection to your changing hormones.
“Leaky gut” is one of those phrases that sits in a strange place: dismissed by some doctors as pure pseudoscience, and sold by others as the hidden cause of nearly every problem you have. Both of those positions are wrong, and the truth in between is more useful than either.
So let’s do what this site always does — separate what’s genuinely established from what’s being oversold, and land somewhere honest. Because there is real science here. There’s just also a lot of marketing wearing its lab coat.
The real thing underneath the buzzword
Start with the actual structure, because it’s genuinely remarkable. The barrier between everything inside your intestines and your bloodstream is, in places, a single layer of cells.1 One cell thick. That thin sheet has to do two opposite jobs at once: let nutrients through, and keep bacteria, toxins, and undigested food out.
What holds that sheet together is a set of protein structures between the cells called tight junctions — built from proteins with names like claudins, occludin, and ZO-1.1 They’re not permanently sealed; they open and close dynamically in response to diet, microbes, immune signals, and stress. “Increased intestinal permeability” — the technical term for leaky gut — simply means those junctions are staying open more than they should.
There’s even a specific protein that regulates this: zonulin, identified by Dr. Alessio Fasano’s team at Harvard, is the main known human molecule that reversibly loosens tight junctions.2 When certain triggers — notably gliadin, a component of gluten, and some bacterial signals — prompt zonulin release, the junctions open. In genetically susceptible people, that response can be exaggerated and prolonged. So the core biology is not made up. It’s real, measurable, and has a named mechanism.
Why the immune system gets involved
Here’s what makes permeability more than a local gut issue. When the barrier stays open, molecules that are supposed to stay in the intestines can cross into the bloodstream — most notably lipopolysaccharides (LPS), fragments of the outer wall of certain gut bacteria.3
Your immune system treats LPS in the bloodstream as a threat, because it is one. It responds with inflammatory signaling molecules — cytokines like TNF-α, IL-6, and IL-1β.3 Done briefly, this is normal defense. The concern with chronic permeability is that this low-grade inflammatory signaling becomes a persistent background hum rather than a short-term response — and chronic inflammation is genuinely linked to a range of conditions.
Where the science stops and the marketing begins
This is the part that matters most, and it’s where honesty separates a trustworthy source from a salesperson.
You’ll hear that leaky gut causes heart disease, diabetes, Alzheimer’s, autoimmunity, depression — essentially every modern illness. That is an overreach. The honest state of the evidence is this: increased intestinal permeability is firmly established in a few specific conditions — celiac disease most clearly, and it’s under serious study in inflammatory bowel disease, type 1 diabetes, and metabolic liver disease.2,4 But the leap from “permeability is real and matters in these specific diseases” to “your leaky gut is causing your depression and your fatigue” is exactly where established science ends and speculation — or a sales pitch — takes over.
The Cleveland Clinic has put it plainly: true, severe intestinal hyperpermeability is too specific and too extreme to explain most people’s everyday symptoms.5 And there’s a testing problem worth knowing about: many commercial “zonulin” blood and stool tests have been questioned, because some assays appear to detect related proteins rather than zonulin itself.6 So if someone sells you a test that “proves” your leaky gut and then sells you the cure for it, that’s the moment your guard should go up.
None of this means the concept is fake. It means the truth is narrower and more honest than the marketing: a real, measurable phenomenon that matters a great deal in some conditions, is plausibly involved in others, and has been stretched into a cure-all it was never shown to be.
The part that actually matters for you after 40
Here’s why this isn’t a generic gut article — because for women moving through perimenopause and beyond, there’s a genuine, research-backed reason your gut barrier may be changing, and it isn’t in most of the leaky-gut content you’ll find.
Estrogen has a direct, protective effect on the gut barrier. It upregulates the tight-junction proteins that hold that single-cell sheet together, which means adequate estrogen actively helps keep permeability low.7 As estrogen declines through the menopausal transition, that support diminishes — and research has associated lower estrogen with increased intestinal permeability, reduced gut microbiome diversity, and greater microbial translocation.7,8
There’s also a two-way loop worth understanding: your gut bacteria help regulate how much estrogen gets reabsorbed and recirculated (through a collection of microbes sometimes called the estrobolome), so the hormone shift and the gut shift feed into each other.8 The honest caveat: much of this is built on small studies and animal models, and large-scale human confirmation is still needed. But the mechanism is real and consistent — estrogen supports the barrier, and its decline is a plausible reason the bloating, sensitivity, and digestive changes so many women notice in midlife are not imaginary.
What the research shows
| What We Know | Intestinal permeability is a real, measurable phenomenon. Tight junctions (claudins, occludin, ZO-1) dynamically regulate the barrier, and zonulin is a confirmed human regulator of them. Permeability is firmly established in celiac disease and under serious study in IBD, type 1 diabetes, and metabolic liver disease. Estrogen protectively upregulates tight-junction proteins, so its decline in menopause is plausibly linked to increased permeability. |
| What We Don’t Know | Whether permeability causes — versus accompanies — most of the everyday symptoms it’s blamed for is largely unproven. Commercial zonulin tests are unreliable. Much of the estrogen-gut research rests on small studies and animal models awaiting large-scale human confirmation. Whether “repairing” the barrier resolves distant symptoms is not established for most conditions. |
| What That Means | Leaky gut is neither pseudoscience nor the cause of all disease — it’s a real phenomenon that’s been oversold. Be especially skeptical of anyone who sells you both the test and the cure. For women after 40, the estrogen connection is the genuinely relevant, under-discussed piece, and it reframes midlife digestive changes as biology, not imagination. |
Where peptides enter the conversation — honestly
Because the gut barrier is built from proteins and repairs itself constantly — the intestinal lining renews every few days — it’s an area of genuine research interest for certain peptides studied for their role in gut-tissue repair and inflammation signaling.
Two you’ll see discussed are BPC-157, studied in animal models for gut-lining repair, and KPV, the alpha-MSH fragment studied for its role in calming the NF-κB inflammatory pathway.9 We cover the actual state of that research on their own pages, with the same honesty applied here: promising mechanisms, largely preclinical evidence, and no license to claim they “cure” anything. What they are not is the effortless fix a supplement label implies — and anyone insisting a single compound reseals your gut and resolves your whole health picture has crossed from science into sales.
For the underlying research, see BPC-157 and KPV in The Peptides.
Sources
1. Tight junction structure (claudins, occludin, ZO-1) and the single-cell epithelial barrier. Zonulin and tight junction reviews, PMC.
2. Fasano A, et al. Intestinal Permeability and its Regulation by Zonulin: Diagnostic and Therapeutic Implications. PMC; celiac and autoimmune associations.
3. LPS translocation and cytokine (TNF-α, IL-6, IL-1β) response to increased permeability. Intestinal permeability reviews, PMC.
4. Fecal Zonulin as a Non-Invasive Marker of Intestinal Permeability (MASLD cohort study). MDPI / PMC, 2025.
5. Cleveland Clinic position on leaky gut syndrome; NICE guidance on dietary management. As summarized in Science Array review, 2026.
6. Scheffler et al., PLoS One 2018; Ajamian et al. 2019 — commercial zonulin assay reliability concerns.
7. Estrogen upregulation of tight-junction proteins; ovariectomy-induced permeability. Physiol Reports (Collins et al., 2017); Int J Women’s Health (Peters et al., 2022).
8. Gut microbiota, estrobolome, and menopausal estrogen regulation. Frontiers in Endocrinology, 2025; Nutrients review, 2026.
9. BPC-157 and KPV gut-repair and anti-inflammatory research — see The Peptides compound pages for full citations.
This article is for research and educational purposes only. Nothing here is medical advice, and nothing here should be read as a recommendation to diagnose or treat any condition. Always consult a qualified healthcare provider regarding your own health.
